IMMUNORREACTIVE AND IMMUNOTHERAPEUTIC MOLECULES INTERACTIONING IN SUBJECTS WITH INSULINODEPENDENT MELLITUS DIABETES (DMID).

摘要

THE PRESENT INVENTION TREATS IN GENERAL OF MOLECULES SUCH AS PEPTIDES, POLYPEPTIDES AND PROTEINS THAT INTERACTION IMMUNOLOGICALLY WITH ANTIBODIES OR CELLS IN SUBJECTS THAT SUFFER AN INSULIN-DETERMINED MELLITUS DIABETES (CLINIC IDDIC). THESE MOLECULES ARE PREFERIBLY IMMUNORREACTIVE AGAINST T-CELLS IN SUBJECTS THAT ARE LOOKING FOR A PRE-CLINICAL OR CLINICAL IDDM, AND RESULT USEFUL FOR THE DEVELOPMENT OF DIAGNOSTIC, THERAPEUTIC, AND PROFILACTIC AGENTS.